A new pharmaceutical podcast putting health heroes in the spotlight debuts in the runup to Rare Diseases Day 2020 with an instalment focusing on Gaucher disease.
London-based health-tech performance marketing agency performance-io has expanded, forming a new creative department and recruiting Amy de la Force as executive creative director.<
Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.